Vinorelbine
Stage III Pancreatic Cancer AJCC v8
OHSU Knight Cancer InstitutePhase 2Active
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 52/ 100
- Competitive Position
- 89/ 100
Competitive context
15 Active assets in the Stage III Pancreatic Cancer AJCC v8 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Letrozole OHSU Knight Cancer Institute | Phase 2 | BB |
Abemaciclib OHSU Knight Cancer Institute | Phase 2 | B |
Telotristat Ethyl Emory University | Phase 2 | B |
Wild-Type Reovirus Northwestern University | Phase 2 | B |
EXEMESTANE OHSU Knight Cancer Institute | Phase 2 | CCC |
View all 18 →
Same molecule, other indications
Vinorelbine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →